US Stock MarketDetailed Quotes

Solid Biosciences (SLDB)

Watchlist
  • 7.380
  • -0.340-4.40%
Close May 13 16:00 ET
  • 7.240
  • -0.140-1.90%
Post 20:01 ET
726.56MMarket Cap-3.84P/E (TTM)

Solid Biosciences (SLDB) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-48.29%-47.23M
-56.27%-156.29M
-80.65%-53.56M
-41.18%-33.47M
-74.28%-37.41M
-26.43%-31.85M
-6.19%-100.01M
-42.37%-29.65M
-32.47%-23.71M
21.84%-21.47M
Net income from continuing operations
-44.44%-56.74M
-39.80%-174.33M
-16.88%-49.79M
-39.88%-45.78M
-57.47%-39.48M
-61.63%-39.28M
-29.87%-124.7M
-109.47%-42.6M
-55.98%-32.73M
-1.80%-25.07M
Operating gains losses
0.00%1.65M
27.37%6.05M
--2.65M
--850K
--900K
--1.65M
--4.75M
----
----
----
Depreciation and amortization
-2.95%395K
-33.36%1.64M
-4.30%467K
-7.16%376K
-68.74%386K
24.46%407K
-4.88%2.46M
129.11%488K
-31.12%405K
75.68%1.24M
Other non cash items
12.66%623K
-72.32%2.13M
-76.20%611K
-92.38%304K
14.48%664K
-2.47%553K
165.16%7.7M
150.68%2.57M
529.18%3.99M
--580K
Change In working capital
28.61%2.31M
-339.37%-6.82M
-722.31%-13.25M
152.93%7.17M
-443.57%-2.54M
162.82%1.79M
132.14%2.85M
184.79%2.13M
132.46%2.84M
111.08%739K
-Change in prepaid assets
-52.84%954K
-226.91%-7.99M
-7,454.81%-7.65M
272.81%1.72M
-1,023.76%-4.08M
201.25%2.02M
-508.86%-2.45M
119.77%104K
-158.86%-993K
124.23%442K
-Change in payables and accrued expense
893.55%1.85M
-57.58%2.96M
-309.31%-5.11M
39.58%5.9M
187.21%1.98M
148.56%186K
190.17%6.97M
261.42%2.44M
18,478.26%4.23M
117.07%688K
-Change in other current liabilities
-19.23%-496K
-6.56%-1.79M
-19.57%-495K
-11.31%-443K
-10.49%-432K
12.05%-416K
3.40%-1.68M
12.66%-414K
10.36%-398K
---391K
Cash from discontinued investing activities
Operating cash flow
-48.29%-47.23M
-56.27%-156.29M
-80.65%-53.56M
-41.18%-33.47M
-74.28%-37.41M
-26.43%-31.85M
-6.19%-100.01M
-42.37%-29.65M
-32.47%-23.71M
21.84%-21.47M
Investing cash flow
Cash flow from continuing investing activities
262.98%44.76M
-263.38%-58.45M
21.90%47.01M
-312.06%-45.27M
-532.38%-32.73M
28.65%-27.46M
-266.02%-16.09M
-14.86%38.57M
55.40%-10.99M
89.27%-5.18M
Net PPE purchase and sale
-30.95%-165K
-64.56%-1.07M
-141.21%-480K
-466.67%-85K
-31.82%-377K
15.44%-126K
57.16%-649K
-121.11%-199K
96.08%-15K
46.64%-286K
Net investment purchase and sale
264.33%44.92M
-271.74%-57.39M
22.72%47.58M
-311.85%-45.19M
-563.39%-32.44M
28.71%-27.34M
-237.78%-15.44M
-14.57%38.77M
54.76%-10.97M
89.75%-4.89M
Net other investing changes
----
----
----
--0
----
----
----
----
--0
--0
Cash from discontinued investing activities
Investing cash flow
262.98%44.76M
-263.38%-58.45M
21.90%47.01M
-312.06%-45.27M
-532.38%-32.73M
28.65%-27.46M
-266.02%-16.09M
-14.86%38.57M
55.40%-10.99M
89.27%-5.18M
Financing cash flow
Cash flow from continuing financing activities
25.98%239.03M
58.81%194.45M
-25.89%5.14M
-63.88%1.18M
-132.02%-1.6M
76.92%189.73M
3,821.75%122.44M
1,274.26%6.94M
3.26M
91.06%5M
Net issuance payments of debt
--0
-52.85%-723K
-58.59%-203K
-102.50%-243K
36.89%-142K
---135K
---473K
---128K
---120K
---225K
Net common stock issuance
25.88%239.01M
59.47%194.74M
-25.38%5.12M
170.49%1.42M
-116.31%-1.66M
77.29%189.86M
4,006.12%122.12M
1,476.32%6.86M
---2.01M
301.02%10.18M
Proceeds from stock option exercised by employees
--18K
-45.72%431K
8.53%229K
--0
31.17%202K
--0
436.49%794K
201.43%211K
--278K
97.44%154K
Net other financing activities
----
----
----
----
----
----
----
----
----
---286K
Cash from discontinued financing activities
Financing cash flow
25.98%239.03M
58.81%194.45M
-25.89%5.14M
-63.88%1.18M
-132.02%-1.6M
76.92%189.73M
3,821.75%122.44M
1,274.26%6.94M
--3.26M
91.06%5M
Net cash flow
Beginning cash position
-24.70%61.89M
8.36%82.19M
-4.58%63.29M
44.08%140.86M
78.05%212.6M
8.36%82.19M
-51.76%75.85M
30.38%66.33M
4.67%97.76M
-28.28%119.41M
Current changes in cash
81.39%236.56M
-420.19%-20.3M
-108.81%-1.4M
-146.73%-77.57M
-231.49%-71.75M
199.40%130.42M
107.79%6.34M
-36.50%15.86M
26.08%-31.44M
70.38%-21.64M
End cash Position
40.38%298.45M
-24.70%61.89M
-24.70%61.89M
-4.58%63.29M
44.08%140.86M
78.05%212.6M
8.36%82.19M
8.36%82.19M
30.38%66.33M
4.67%97.76M
Free cash flow
-48.22%-47.4M
-56.40%-157.44M
-81.31%-54.12M
-41.45%-33.56M
-73.72%-37.79M
-26.18%-31.98M
-5.19%-100.67M
-42.73%-29.85M
-29.78%-23.72M
22.31%-21.75M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -48.29%-47.23M-56.27%-156.29M-80.65%-53.56M-41.18%-33.47M-74.28%-37.41M-26.43%-31.85M-6.19%-100.01M-42.37%-29.65M-32.47%-23.71M21.84%-21.47M
Net income from continuing operations -44.44%-56.74M-39.80%-174.33M-16.88%-49.79M-39.88%-45.78M-57.47%-39.48M-61.63%-39.28M-29.87%-124.7M-109.47%-42.6M-55.98%-32.73M-1.80%-25.07M
Operating gains losses 0.00%1.65M27.37%6.05M--2.65M--850K--900K--1.65M--4.75M------------
Depreciation and amortization -2.95%395K-33.36%1.64M-4.30%467K-7.16%376K-68.74%386K24.46%407K-4.88%2.46M129.11%488K-31.12%405K75.68%1.24M
Other non cash items 12.66%623K-72.32%2.13M-76.20%611K-92.38%304K14.48%664K-2.47%553K165.16%7.7M150.68%2.57M529.18%3.99M--580K
Change In working capital 28.61%2.31M-339.37%-6.82M-722.31%-13.25M152.93%7.17M-443.57%-2.54M162.82%1.79M132.14%2.85M184.79%2.13M132.46%2.84M111.08%739K
-Change in prepaid assets -52.84%954K-226.91%-7.99M-7,454.81%-7.65M272.81%1.72M-1,023.76%-4.08M201.25%2.02M-508.86%-2.45M119.77%104K-158.86%-993K124.23%442K
-Change in payables and accrued expense 893.55%1.85M-57.58%2.96M-309.31%-5.11M39.58%5.9M187.21%1.98M148.56%186K190.17%6.97M261.42%2.44M18,478.26%4.23M117.07%688K
-Change in other current liabilities -19.23%-496K-6.56%-1.79M-19.57%-495K-11.31%-443K-10.49%-432K12.05%-416K3.40%-1.68M12.66%-414K10.36%-398K---391K
Cash from discontinued investing activities
Operating cash flow -48.29%-47.23M-56.27%-156.29M-80.65%-53.56M-41.18%-33.47M-74.28%-37.41M-26.43%-31.85M-6.19%-100.01M-42.37%-29.65M-32.47%-23.71M21.84%-21.47M
Investing cash flow
Cash flow from continuing investing activities 262.98%44.76M-263.38%-58.45M21.90%47.01M-312.06%-45.27M-532.38%-32.73M28.65%-27.46M-266.02%-16.09M-14.86%38.57M55.40%-10.99M89.27%-5.18M
Net PPE purchase and sale -30.95%-165K-64.56%-1.07M-141.21%-480K-466.67%-85K-31.82%-377K15.44%-126K57.16%-649K-121.11%-199K96.08%-15K46.64%-286K
Net investment purchase and sale 264.33%44.92M-271.74%-57.39M22.72%47.58M-311.85%-45.19M-563.39%-32.44M28.71%-27.34M-237.78%-15.44M-14.57%38.77M54.76%-10.97M89.75%-4.89M
Net other investing changes --------------0------------------0--0
Cash from discontinued investing activities
Investing cash flow 262.98%44.76M-263.38%-58.45M21.90%47.01M-312.06%-45.27M-532.38%-32.73M28.65%-27.46M-266.02%-16.09M-14.86%38.57M55.40%-10.99M89.27%-5.18M
Financing cash flow
Cash flow from continuing financing activities 25.98%239.03M58.81%194.45M-25.89%5.14M-63.88%1.18M-132.02%-1.6M76.92%189.73M3,821.75%122.44M1,274.26%6.94M3.26M91.06%5M
Net issuance payments of debt --0-52.85%-723K-58.59%-203K-102.50%-243K36.89%-142K---135K---473K---128K---120K---225K
Net common stock issuance 25.88%239.01M59.47%194.74M-25.38%5.12M170.49%1.42M-116.31%-1.66M77.29%189.86M4,006.12%122.12M1,476.32%6.86M---2.01M301.02%10.18M
Proceeds from stock option exercised by employees --18K-45.72%431K8.53%229K--031.17%202K--0436.49%794K201.43%211K--278K97.44%154K
Net other financing activities ---------------------------------------286K
Cash from discontinued financing activities
Financing cash flow 25.98%239.03M58.81%194.45M-25.89%5.14M-63.88%1.18M-132.02%-1.6M76.92%189.73M3,821.75%122.44M1,274.26%6.94M--3.26M91.06%5M
Net cash flow
Beginning cash position -24.70%61.89M8.36%82.19M-4.58%63.29M44.08%140.86M78.05%212.6M8.36%82.19M-51.76%75.85M30.38%66.33M4.67%97.76M-28.28%119.41M
Current changes in cash 81.39%236.56M-420.19%-20.3M-108.81%-1.4M-146.73%-77.57M-231.49%-71.75M199.40%130.42M107.79%6.34M-36.50%15.86M26.08%-31.44M70.38%-21.64M
End cash Position 40.38%298.45M-24.70%61.89M-24.70%61.89M-4.58%63.29M44.08%140.86M78.05%212.6M8.36%82.19M8.36%82.19M30.38%66.33M4.67%97.76M
Free cash flow -48.22%-47.4M-56.40%-157.44M-81.31%-54.12M-41.45%-33.56M-73.72%-37.79M-26.18%-31.98M-5.19%-100.67M-42.73%-29.85M-29.78%-23.72M22.31%-21.75M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More